Novartis pays PeptiDream $180M as radiopharma big bang continues
Novartis pays PeptiDream $180M as radiopharma big bang continues ntaylor Tue, 04/30/2024 - 04:14
Novartis pays PeptiDream $180M as radiopharma big bang continues ntaylor Tue, 04/30/2024 - 04:14
Todd Lehman takes over as CEO at LumaBridge hfloersh Mon, 04/29/2024 - 12:43
FDA wants to hear from you on future of advisory committee meetings aarmstrong Mon, 04/29/2024 - 12:31
Annovis' shares plummet 60% on another failure for lead Alzheimer's med aarmstrong Mon, 04/29/2024 - 11:20
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23 kdunleavy Mon, 04/29/2024 - 07:56
Janssen-partnered epilepsy drug fails phase 2 trial in latest bad luck for Addex jwaldron Mon, 04/29/2024 - 06:28
Bristol Myers pays $65M to expand Repertoire of autoimmune assets ntaylor Mon, 04/29/2024 - 05:14
Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site mbayer Fri, 04/26/2024 - 10:34
Gilead gives up on $4.9B antibody as solid tumor plan unravels ntaylor Fri, 04/26/2024 - 09:39
Pfizer collab with Austrian research institute leads to new AI models for drug discovery hfloersh Thu, 04/25/2024 - 17:04